HUSAM ALATHARI: Open Payments
NPI 1477574549 · FALLS CHURCH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$938 in 42 payments from 12 companies in 2025. Trend: 2023 $15,537 · 2024 $4,103 · 2025 $938
Food & beverage: $938
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $291 |
| Axsome Therapeutics, Inc. | 4 | $122 |
| Vanda Pharmaceuticals Inc. | 3 | $102 |
| Corium, LLC | 3 | $69 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| Alkermes, Inc. | 3 | $60 |
| Supernus Pharmaceuticals, Inc. | 3 | $59 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $47 |
| Neuronetics, Inc. | 1 | $43 |
| Lundbeck LLC | 2 | $41 |
Products named: VRAYLAR, Auvelity, HETLIOZ, Azstarys, Qelbree, REXULTI, CAPLYTA, ABILIFY ASIMTUFII.
Industry payments across VA — which companies pay providers there.
